1. Home
  2. CADL vs CRUS Comparison

CADL vs CRUS Comparison

Compare CADL & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • CRUS
  • Stock Information
  • Founded
  • CADL 1999
  • CRUS 1984
  • Country
  • CADL United States
  • CRUS United States
  • Employees
  • CADL N/A
  • CRUS N/A
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • CRUS Semiconductors
  • Sector
  • CADL Health Care
  • CRUS Technology
  • Exchange
  • CADL Nasdaq
  • CRUS Nasdaq
  • Market Cap
  • CADL 185.2M
  • CRUS N/A
  • IPO Year
  • CADL 2021
  • CRUS 1989
  • Fundamental
  • Price
  • CADL $6.20
  • CRUS $137.71
  • Analyst Decision
  • CADL Strong Buy
  • CRUS Strong Buy
  • Analyst Count
  • CADL 1
  • CRUS 8
  • Target Price
  • CADL $11.00
  • CRUS $122.86
  • AVG Volume (30 Days)
  • CADL 590.6K
  • CRUS 448.9K
  • Earning Date
  • CADL 08-08-2024
  • CRUS 08-06-2024
  • Dividend Yield
  • CADL N/A
  • CRUS N/A
  • EPS Growth
  • CADL N/A
  • CRUS 58.58
  • EPS
  • CADL N/A
  • CRUS 4.90
  • Revenue
  • CADL N/A
  • CRUS $1,788,890,000.00
  • Revenue This Year
  • CADL N/A
  • CRUS $3.02
  • Revenue Next Year
  • CADL N/A
  • CRUS $7.49
  • P/E Ratio
  • CADL N/A
  • CRUS $28.15
  • Revenue Growth
  • CADL N/A
  • CRUS N/A
  • 52 Week Low
  • CADL $0.66
  • CRUS $65.02
  • 52 Week High
  • CADL $14.30
  • CRUS $142.83
  • Technical
  • Relative Strength Index (RSI)
  • CADL 45.08
  • CRUS 62.90
  • Support Level
  • CADL $5.75
  • CRUS $134.01
  • Resistance Level
  • CADL $7.34
  • CRUS $140.88
  • Average True Range (ATR)
  • CADL 0.50
  • CRUS 3.48
  • MACD
  • CADL 0.12
  • CRUS -0.40
  • Stochastic Oscillator
  • CADL 33.47
  • CRUS 65.68

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: